Latest News & Features
Asia-Pacific
The Australian government has rejected proposals by the Productivity Commission regarding extending the length of pharmaceutical patents. 31 August 2017
Americas
The Federal Trade Commission has approved a final order combating the anticompetitive effects resulting from Baxter’s proposed $625 million acquisition of Claris’s injectable drugs business. 31 August 2017
Big Pharma
The practical implications of Brexit, including on the Unified Patent Court, were the focus of a roundtable discussion at Life Sciences Patent Network North America, an industry event. 31 August 2017
Big Pharma
The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry. 30 August 2017
Asia
AstraZeneca and Takeda have entered into an agreement to develop and commercialise MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease. 29 August 2017
Americas
Gilead Sciences is to acquire Kite Pharma for $11.9 billion, after the deal was unanimously approved by both companies’ boards of directors. 29 August 2017
Big Pharma
With Brexit negotiations well under way, Nicola Dagg, global head of IP at Allen & Overy, says ensuring that all of the regulatory and compliance requirements are in place immediately after Britain leaves the EU is the most important aspect of negotiations for the life sciences. 25 August 2017
Americas
Brazil’s Ministry of Health has published the entire list of the 2017 proposals to be considered for the Partnership for Product Development. 25 August 2017
Americas
Law firm Cantor Colburn has achieved the highest rate of successful allowances for patent applications following section 101 rejections citing the Mayo and Myriad precedents, according to data compiled by research firm Juristat. 25 August 2017
Big Pharma
Pharmaceutical company AbbVie’s attempt to obtain an extension on its Humira patents has been rejected by an Australian court. 24 August 2017